Heart Disease News and Research

Latest Heart Disease News and Research

Monthly contact with counselor provides some benefit for maintaining weight loss

Weight-loss program participants who had a brief, monthly personal contact intervention - most often a 10-15 minute phone conversation - regained less weight than participants who were in a Web-based intervention or self-directed program, according to a study in the March 12 issue of JAMA, the Journal of the American Medical Association.

12 Mar 2008

Less education may mean shorter life

It's no secret that over the last few decades, life expectancy in the United States has been rising.

12 Mar 2008

Glaucoma associated with increased risk of cardiovascular death in black patients

In a population of African origin, persons with diagnosed and treated glaucoma appeared to have an increased risk of death from cardiovascular causes, according to a study by Suh-Yuh Wu, and colleagues in the Departments of Preventive Medicine and Ophthalmology at Stony Brook University, the University of the West Indies, and the Cleveland Clinic Foundation.

12 Mar 2008

Combined therapeutic approach of stenting and photodynamic therapy improves survival in late stage liver cancer patients

A combined therapeutic approach of stenting and photodynamic therapy may improve survival rates for patients suffering from advanced liver bile duct cancer, according to a study published this month in Clinical Gastroenterology and Hepatology , the official journal of the American Gastroenterological Association (AGA) Institute.

12 Mar 2008

Experts says remote Aboriginal communities lack the means to prepare and store food

An expert in Aboriginal health has warned of the need for urgent practical measures to reduce the life expectancy gap between Aboriginal Australians and the rest of the population.

12 Mar 2008

Toddler takes sildenafil in order to survive

A two year old in Britain has a rare condition that causes chronic high blood pressure and must take Viagra to stay alive.

12 Mar 2008

Life gets longer but only for the educated

New research has revealed that while life expectancy in the United States has risen in the last decades not everyone has benefited from the increased long levity.

11 Mar 2008

Personal counseling and web-based strategies show modest success for sustaining weight loss

Adults who lost weight in a six-month program were able to keep at least some of the weight off for 2.5 years with the help of brief monthly personal counseling, according to a new study from the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health. A Web-based intervention also helped participants keep the weight off for two years, but the benefit waned during the last six months of the trial

11 Mar 2008

Weight-loss more effective than intensive insulin therapy for type 2 diabetics, according to expert

Weight-loss and major lifestyle changes may be more effective than intensive insulin therapy for overweight patients with poorly controlled, insulin-resistant type 2 diabetes, according to a diabetes researcher at UT Southwestern Medical Center.

11 Mar 2008

Survival after cardiac arrest increases three-fold with new resuscitation protocol

A new paramedic resuscitation method called Cardiocerebral Resuscitation has resulted in a three-fold increase in the survival rates of out-of-hospital cardiac arrest. The results are published in the March 12 issue of one the world's foremost medical journals, the Journal of the American Medical Association (JAMA).

11 Mar 2008

Discovery of new protein family that may play an important role in preventing inflammatory diseases

A University of Central Florida research team has discovered a new protein family that may play an important role in preventing inflammatory diseases such as arthritis, some forms of cancer and even heart disease.

11 Mar 2008

Potential new gene therapy strategy for muscle-wasting diseases

Investigators in The Research Institute at Nationwide Children's Hospital have identified the role of a protein that could potentially lead to new clinical treatments to combat musculoskeletal diseases, including Duchenne muscular dystrophy (DMD).

11 Mar 2008

Poor sleep more dangerous for women

Researchers at Duke University Medical Center say they may have figured out why poor sleep does more harm to cardiovascular health in women than in men.

11 Mar 2008

Long-term effects of synthetic progestins cause for concern

The widely used synthetic progestin medroxyprogesterone acetate (MPA) decreased endothelial function in premenopausal women in a study done at the University of Oregon.

11 Mar 2008

Magnesium linked to lower risk for some strokes in male smokers

Male smokers who consume more magnesium appear to have a lower risk for cerebral infarction, a type of stroke that occurs when blood flow to the brain is blocked, according to a report in the March 10 issue of Archives of Internal Medicine.

11 Mar 2008

Study aims to improve treatment for children born with heart defects

Trying to understand and stop the collateral lung damage that can occur in babies with congenital heart disease is the focus of a new study.

11 Mar 2008

How do infections and toxins launch a cell's self-destruct and alarm system?

Cells are coded with several programs for self-destruction.

11 Mar 2008

Glaucoma associated with increased risk of cardiovascular death in black patients

Black patients with diagnosed and treated glaucoma and those with high pressure in their eyes appear to have an increased risk of death from cardiovascular causes, according to a report in the March issue of Archives of Ophthalmology, one of the JAMA/Archives journals.

11 Mar 2008

Femara helps protect against return of breast cancer after completing Tamoxifen therapy

Women may reduce the risk of their breast cancer returning by starting treatment with Femara (letrozole tablets) anywhere from one to seven years after finishing tamoxifen therapy, according to a new analysis published in the Journal of Clinical Oncology.

11 Mar 2008

Cardiac effects associated with breast cancer treatment appear lower with dose-dense chemotherapy

A new pilot study by investigators at Memorial Sloan-Kettering Cancer Center (MSKCC) found that breast cancer patients can be treated safely with a "dose-dense" regimen of standard chemotherapy agents and the antibody trastuzumab (Herceptin), a drug that has previously been shown to cause cardiac toxicity.

11 Mar 2008

Heart Disease News and Research

Latest Heart Disease News and Research

Monthly contact with counselor provides some benefit for maintaining weight loss

Less education may mean shorter life

Glaucoma associated with increased risk of cardiovascular death in black patients

Combined therapeutic approach of stenting and photodynamic therapy improves survival in late stage liver cancer patients

Experts says remote Aboriginal communities lack the means to prepare and store food

Toddler takes sildenafil in order to survive

Life gets longer but only for the educated

Personal counseling and web-based strategies show modest success for sustaining weight loss

Weight-loss more effective than intensive insulin therapy for type 2 diabetics, according to expert

Survival after cardiac arrest increases three-fold with new resuscitation protocol

Discovery of new protein family that may play an important role in preventing inflammatory diseases

Potential new gene therapy strategy for muscle-wasting diseases

Poor sleep more dangerous for women

Long-term effects of synthetic progestins cause for concern

Magnesium linked to lower risk for some strokes in male smokers

Study aims to improve treatment for children born with heart defects

How do infections and toxins launch a cell's self-destruct and alarm system?

Glaucoma associated with increased risk of cardiovascular death in black patients

Femara helps protect against return of breast cancer after completing Tamoxifen therapy

Cardiac effects associated with breast cancer treatment appear lower with dose-dense chemotherapy

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Heart Disease News and Research

Latest Heart Disease News and Research

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Newsletters you may be interested in